HIV AND HEPATITIS POLICY INSTITUTE

Lobbying for HIV AND HEPATITIS POLICY INSTITUTE · Patient advocacy

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 expenses · posted Jan 20, 2026

Lobbying activity 4

Budget/Appropriations

CDC domestic HIV and hepatitis prevention, Ryan White HIV/AIDS Program, Ending the HIV Epidemic Initiative, including PrEP activities for community health centers, Minority AIDS Initiative, and NIH AIDS research

Health Issues

Ending the HIV Epidemic initiative, PrEP coverage, CDC HIV Prevention Programs, Ryan White HIV/AIDS Program, Community Health Centers PrEP Program

Insurance

Preventive Service insurance coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs, Essential Health Benefits & Prescription Drugs

Pharmacy

Preventive Service coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs; Essential Health Benefits & Prescription Drugs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.